A Pharmacophore for Drugs Targeting the α4α4 Binding Site of the (α4)<sub>3</sub>(β2)<sub>2</sub> Nicotinic Acetylcholine Receptor. [PDF]
Kusay AS, Luo Y, O'Mara ML, Balle T.
europepmc +1 more source
Non-neuronal cholinergic stimulation favors bone mass accrual. [PDF]
Tamimi F +7 more
europepmc +1 more source
Targeting GPR3 as a novel approach for nicotine cessation therapeutic development. [PDF]
Mogul AS +6 more
europepmc +1 more source
Correction to: 'Unravelling nicotinic receptor and ligand features underlying neonicotinoid knockdown actions on the malaria vector mosquito <i>Anopheles gambiae</i>' (2024), by Ito <i>et al.</i> [PDF]
Ito R +16 more
europepmc +1 more source
An alpha7 nicotinic acetylcholine receptor agonist induces retinal neurogenesis and restores electrophysiological function following blast-induced ocular trauma in adult mice. [PDF]
Nolasco de Carvalho GV +3 more
europepmc +1 more source
Molecular insights into the α6β4 nicotinic acetylcholine receptor function and ligand recognition. [PDF]
Su J +10 more
europepmc +1 more source
Genetic and pharmacological targeting of nicotinic acetylcholine receptor action blocks tumor progression in mouse models of breast cancer. [PDF]
Heard MA +9 more
europepmc +1 more source

